Pyrimidyl cyclopentanes as AKT protein kinase inhibitors

Details for Australian Patent Application No. 2008272830 (hide)

Owner Genentech Inc. Array BioPharma Inc.

Inventors Bencsik, Josef; Spencer, Keith L.; Schlacter, Stephen T.; Mitchell, Ian S.; Xu, Rui; Xiao, Dengming; Welch, Mike; Blake, James F.; Kallan, Nicholas C.; Safina, Brian S.; Graham, James M.; Liang, Jun; Hentemann, Martin F.

Agent Pizzeys

Pub. Number AU-A-2008272830

PCT Pub. Number WO2009/006567

Priority 61/020,088 09.01.08 US; 60/948,138 05.07.07 US

Filing date 3 July 2008

Wipo publication date 8 January 2009

International Classifications

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

11 February 2010 PCT application entered the National Phase

  PCT publication WO2009/006567 Priority application(s): WO2009/006567

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008272832-Pyrimidyl cyclopentanes as AKT protein kinase inhibitors

2008272818-Methods, composition, targets for combinational cancer treatments